$2.83 Billion is the total value of HealthCor Management, L.P.'s 83 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 146.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB L | $158,829,000 | +2.5% | 1,725,650 | -18.5% | 5.62% | -6.0% |
| VRTX | Buy | VERTEX PHARMACEUTICALS INC | $143,216,000 | +3.9% | 666,460 | +14.3% | 5.07% | -4.7% |
| ZBH | Buy | ZIMMER BIOMET HOLDINGS INC | $121,610,000 | +43.1% | 759,680 | +37.8% | 4.30% | +31.3% |
| DHR | New | DANAHER CORPORATION | $120,569,000 | – | 535,670 | +100.0% | 4.27% | – |
| HUM | Buy | HUMANA INC | $105,395,000 | +16.7% | 251,390 | +14.2% | 3.73% | +7.0% |
| MDT | Buy | MEDTRONIC PLC | $94,044,000 | +32.9% | 796,110 | +31.8% | 3.33% | +21.9% |
| INCY | Buy | INCYTE CORP | $92,996,000 | +5373.6% | 1,144,287 | +5759.1% | 3.29% | +4884.8% |
| MCK | Buy | MCKESSON CORP | $92,318,000 | +25.5% | 473,330 | +12.0% | 3.27% | +15.2% |
| MRVI | Sell | MARAVAI LIFESCIENCES HLDGS I | $85,989,000 | -2.2% | 2,412,712 | -23.0% | 3.04% | -10.3% |
| EHC | New | ENCOMPASS HEALTH CORP | $82,335,000 | – | 1,005,316 | +100.0% | 2.91% | – |
| AGIO | Buy | AGIOS PHARMACEUTICALS INC | $79,162,000 | +83.2% | 1,532,960 | +53.7% | 2.80% | +68.1% |
| ABBV | Sell | ABBVIE INC | $78,938,000 | -13.7% | 729,420 | -14.6% | 2.79% | -20.8% |
| HCA | Sell | HCA HEALTHCARE INC | $78,159,000 | -33.2% | 414,990 | -41.7% | 2.76% | -38.7% |
| IQV | Sell | IQVIA HLDGS INC | $77,582,000 | -46.1% | 401,690 | -50.0% | 2.74% | -50.5% |
| ABC | New | AMERISOURCEBERGEN CORP | $68,869,000 | – | 583,290 | +100.0% | 2.44% | – |
| WOOF | New | PETCO HEALTH & WELLNESS CO I | $68,430,000 | – | 3,088,000 | +100.0% | 2.42% | – |
| ZTS | New | ZOETIS INCcl a | $66,435,000 | – | 421,860 | +100.0% | 2.35% | – |
| WELL | Buy | WELLTOWER INC | $66,404,000 | +187.7% | 927,040 | +159.6% | 2.35% | +163.9% |
| VTR | Buy | VENTAS INC | $61,334,000 | +90.0% | 1,149,860 | +74.7% | 2.17% | +74.3% |
| NVST | Buy | ENVISTA HOLDINGS CORPORATION | $58,563,000 | +67.1% | 1,435,370 | +38.1% | 2.07% | +53.3% |
| DXCM | New | DEXCOM INC | $51,073,000 | – | 142,110 | +100.0% | 1.81% | – |
| BCRX | New | BIOCRYST PHARMACEUTICALS INC | $49,695,000 | – | 4,886,440 | +100.0% | 1.76% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $45,407,000 | – | 1,174,820 | +100.0% | 1.61% | – |
| COO | Sell | COOPER COS INC | $43,466,000 | -65.4% | 113,167 | -67.3% | 1.54% | -68.2% |
| QGEN | New | QIAGEN NV | $40,822,000 | – | 838,414 | +100.0% | 1.44% | – |
| VRTX | New | VERTEX PHARMACEUTICALS INCcall | $40,184,000 | – | 187,000 | +100.0% | 1.42% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $38,698,000 | – | 71,460 | +100.0% | 1.37% | – |
| CNMD | Buy | CONMED CORP | $36,166,000 | +222.9% | 276,940 | +176.9% | 1.28% | +196.3% |
| SPY | Buy | SPDR S&P 500 ETF TRput | $33,688,000 | +20.1% | 85,000 | +13.3% | 1.19% | +10.3% |
| GH | Sell | GUARDANT HEALTH INC | $33,476,000 | -52.2% | 219,300 | -59.6% | 1.18% | -56.1% |
| ANTM | New | ANTHEM INC | $32,937,000 | – | 91,760 | +100.0% | 1.16% | – |
| NUAN | New | NUANCE COMMUNICATIONS INC | $32,382,000 | – | 742,030 | +100.0% | 1.15% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $31,084,000 | – | 745,605 | +100.0% | 1.10% | – |
| SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $30,666,000 | +28.8% | 1,371,480 | +28.1% | 1.08% | +18.2% |
| IWM | Buy | ISHARES TRput | $29,827,000 | +44.9% | 135,000 | +28.6% | 1.06% | +32.9% |
| QQQ | Sell | INVESCO QQQ TRput | $28,722,000 | -34.6% | 90,000 | -35.7% | 1.02% | -40.0% |
| RPRX | Sell | ROYALTY PHARMA PLC | $25,770,000 | -61.6% | 590,790 | -55.9% | 0.91% | -64.7% |
| RARE | New | ULTRAGENYX PHARMACEUTICAL IN | $23,638,000 | – | 207,610 | +100.0% | 0.84% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $23,233,000 | – | 900,490 | +100.0% | 0.82% | – |
| BIIB | Buy | BIOGEN INC | $22,523,000 | +862.1% | 80,510 | +742.2% | 0.80% | +785.6% |
| VEEV | New | VEEVA SYS INC | $22,441,000 | – | 85,900 | +100.0% | 0.79% | – |
| SHC | New | SOTERA HEALTH CO | $20,098,000 | – | 805,220 | +100.0% | 0.71% | – |
| LGVU | New | LONGVIEW ACQUISITION CORP IIunit 99/99/9999 | $17,570,000 | – | 1,750,000 | +100.0% | 0.62% | – |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $17,461,000 | – | 494,640 | +100.0% | 0.62% | – |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $17,175,000 | -11.9% | 227,450 | +2.4% | 0.61% | -19.0% |
| HAE | Sell | HAEMONETICS CORP MASS | $16,483,000 | -75.5% | 148,480 | -73.8% | 0.58% | -77.5% |
| TVTX | New | TRAVERE THERAPEUTICS INC | $15,444,000 | – | 618,520 | +100.0% | 0.55% | – |
| RCUS | New | ARCUS BIOSCIENCES INC | $15,078,000 | – | 536,970 | +100.0% | 0.53% | – |
| EHTH | New | EHEALTH INC | $13,091,000 | – | 180,000 | +100.0% | 0.46% | – |
| AFMD | New | AFFIMED N V | $12,561,000 | – | 1,587,944 | +100.0% | 0.44% | – |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $12,336,000 | -87.1% | 950,000 | -86.3% | 0.44% | -88.2% |
| ARYD | New | ARYA SCIENCES ACQU CORP IVcl a | $12,141,000 | – | 1,159,360 | +100.0% | 0.43% | – |
| CRIS | Sell | CURIS INC | $11,070,000 | -43.1% | 977,950 | -58.8% | 0.39% | -47.7% |
| CYTK | New | CYTOKINETICS INC | $10,758,000 | – | 462,500 | +100.0% | 0.38% | – |
| RACB | New | RESEARCH ALLIANCE CORP II | $10,250,000 | – | 1,000,000 | +100.0% | 0.36% | – |
| IKNA | New | IKENA ONCOLOGY INC | $9,639,000 | – | 341,212 | +100.0% | 0.34% | – |
| ICUI | New | ICU MED INC | $9,031,000 | – | 43,960 | +100.0% | 0.32% | – |
| IDXX | New | IDEXX LABS INC | $9,008,000 | – | 18,410 | +100.0% | 0.32% | – |
| INNV | New | INNOVAGE HLDG CORP | $8,382,000 | – | 325,000 | +100.0% | 0.30% | – |
| IRWD | New | IRONWOOD PHARMACEUTICALS INC | $8,231,000 | – | 736,201 | +100.0% | 0.29% | – |
| MSACU | New | MEDICUS SCIENCES ACQUISITIONunit 99/99/9999 | $7,782,000 | – | 790,000 | +100.0% | 0.28% | – |
| OHPAU | New | ORION ACQUISITION CORPunit 02/19/2026 | $5,829,000 | – | 582,920 | +100.0% | 0.21% | – |
| CERN | New | CERNER CORP | $5,349,000 | – | 74,420 | +100.0% | 0.19% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEWcall | $5,253,000 | – | 255,000 | +100.0% | 0.19% | – |
| TIL | New | INSTIL BIO INC | $5,016,000 | – | 200,000 | +100.0% | 0.18% | – |
| OMEG | New | OMEGA ALPHA SPACcl a | $3,713,000 | – | 375,000 | +100.0% | 0.13% | – |
| FSII | New | FS DEVELOPMENT CORP II | $3,486,000 | – | 350,000 | +100.0% | 0.12% | – |
| ABGI | New | ABG ACQUISITION CORP I | $3,462,000 | – | 350,000 | +100.0% | 0.12% | – |
| EUCRU | New | EUCRATES BIOMEDICAL ACQU CORunit 10/23/2027 | $3,362,000 | – | 334,180 | +100.0% | 0.12% | – |
| SRSAU | New | SARISSA CAPITAL ACQUISITN COunit 10/23/2027 | $2,839,000 | – | 262,150 | +100.0% | 0.10% | – |
| GLPG | New | GALAPAGOS NVspon adr | $2,641,000 | – | 34,260 | +100.0% | 0.09% | – |
| FNCH | New | FINCH THERAPEUTICS GROUP INC | $2,423,000 | – | 150,000 | +100.0% | 0.09% | – |
| CMIIU | New | CM LIFE SCIENCES II INCunit 02/25/2028 | $2,222,000 | – | 173,563 | +100.0% | 0.08% | – |
| JNCE | New | JOUNCE THERAPEUTICS INC | $2,081,000 | – | 202,585 | +100.0% | 0.07% | – |
| JYAC | New | JIYA ACQUISITION CORP | $1,384,000 | – | 140,680 | +100.0% | 0.05% | – |
| KIN | New | KINDRED BIOSCIENCES INC | $1,320,000 | – | 265,580 | +100.0% | 0.05% | – |
| MRUS | New | MERUS N V | $1,264,000 | – | 60,490 | +100.0% | 0.04% | – |
| CNTB | New | CONNECT BIOPHARMA HLDGS LTDads | $1,110,000 | – | 60,000 | +100.0% | 0.04% | – |
| OMER | New | OMEROS CORP | $890,000 | – | 50,000 | +100.0% | 0.03% | – |
| HLXA | New | HELIX ACQUISITION CORP | $613,000 | – | 60,027 | +100.0% | 0.02% | – |
| ANIK | Sell | ANIKA THERAPEUTICS INC | $552,000 | -40.0% | 13,540 | -33.4% | 0.02% | -42.9% |
| MREO | New | MEREO BIOPHARMA GROUP PLCads | $503,000 | – | 149,170 | +100.0% | 0.02% | – |
| BCTG | New | BCTG ACQUISITION CORP | $456,000 | – | 41,032 | +100.0% | 0.02% | – |
| FPRX | Exit | FIVE PRIME THERAPEUTICS INC | $0 | – | -86,930 | -100.0% | -0.06% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -8,502 | -100.0% | -0.07% | – |
| ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -55,150 | -100.0% | -0.07% | – |
| AMRN | Exit | AMARIN CORP PLCspons adr new | $0 | – | -392,760 | -100.0% | -0.07% | – |
| CERT | Exit | CERTARA INC | $0 | – | -150,000 | -100.0% | -0.20% | – |
| TFX | Exit | TELEFLEX INCORPORATED | $0 | – | -13,150 | -100.0% | -0.21% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INCput | $0 | – | -250,000 | -100.0% | -0.22% | – |
| DCPH | Exit | DECIPHERA PHARMACEUTICALS IN | $0 | – | -139,210 | -100.0% | -0.31% | – |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -61,330 | -100.0% | -0.37% | – |
| THC | Exit | TENET HEALTHCARE CORP | $0 | – | -431,441 | -100.0% | -0.66% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -226,460 | -100.0% | -0.84% | – |
| CRL | Exit | CHARLES RIV LABS INTL INC | $0 | – | -107,800 | -100.0% | -1.04% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -156,046 | -100.0% | -1.04% | – |
| OHI | Exit | OMEGA HEALTHCARE INVS INC | $0 | – | -770,910 | -100.0% | -1.08% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -270,250 | -100.0% | -1.08% | – |
| HZNP | Exit | HORIZON THERAPEUTICS PUB Lcall | $0 | – | -400,000 | -100.0% | -1.13% | – |
| EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -321,200 | -100.0% | -1.13% | – |
| LIVN | Exit | LIVANOVA PLC | $0 | – | -616,030 | -100.0% | -1.57% | – |
| SYNH | Exit | SYNEOS HEALTH INCcl a | $0 | – | -793,320 | -100.0% | -2.08% | – |
| UNH | Exit | UNITEDHEALTH GROUP INC | $0 | – | -174,990 | -100.0% | -2.37% | – |
| JNJ | Exit | JOHNSON & JOHNSON | $0 | – | -435,010 | -100.0% | -2.64% | – |
| HOLX | Exit | HOLOGIC INC | $0 | – | -1,017,280 | -100.0% | -2.86% | – |
| BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -1,297,700 | -100.0% | -3.10% | – |
| BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -140,080 | -100.0% | -3.15% | – |
| MDGL | Exit | MADRIGAL PHARMACEUTICALS INC | $0 | – | -902,601 | -100.0% | -3.87% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-17
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HCA HOLDINGS INC | 27 | Q1 2022 | 6.2% |
| ZIMMER HLDGS INC | 26 | Q2 2022 | 9.3% |
| DANAHER CORPORATION | 26 | Q3 2022 | 5.6% |
| NEUROCRINE BIOSCIENCES INC | 26 | Q4 2022 | 7.8% |
| UNITEDHEALTH GROUP INC | 24 | Q3 2022 | 6.4% |
| VERTEX PHARMACEUTICALS INC | 24 | Q3 2021 | 5.3% |
| HUMANA INC | 22 | Q3 2022 | 6.6% |
| BRISTOL-MYERS SQUIBB CO | 22 | Q3 2022 | 9.2% |
| BIOGEN INC | 21 | Q3 2022 | 8.5% |
| LABORATORY CORP AMER HLDGS | 20 | Q2 2020 | 8.3% |
View HealthCor Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CareView Communications Inc | May 26, 2023 | 186,970,000 | 32.0% |
| Research Alliance Corp. IISold out | February 14, 2023 | 0 | 0.0% |
| ARYA Sciences Acquisition Corp IVSold out | February 14, 2022 | 0 | 0.0% |
| Aurinia Pharmaceuticals Inc.Sold out | February 14, 2022 | 0 | 0.0% |
| MADRIGAL PHARMACEUTICALS, INC.Sold out | February 14, 2022 | 0 | 0.0% |
| Medicus Sciences Acquisition Corp.Sold out | February 14, 2022 | 0 | 0.0% |
| Arcturus Therapeutics Holdings Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| Intersect ENT, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
| NEVRO CORP | February 12, 2021 | 156,046 | 0.5% |
| ViewRay, Inc.Sold out | February 12, 2021 | 0 | 0.0% |
View HealthCor Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2023-05-26 |
| 4 | 2023-05-26 |
| SC 13D/A | 2023-05-26 |
| 4 | 2023-04-04 |
| 4 | 2023-04-04 |
| SC 13D/A | 2023-04-03 |
| 13F-HR | 2023-02-15 |
| SC 13G/A | 2023-02-14 |
| 4 | 2023-01-04 |
| 4 | 2023-01-04 |
View HealthCor Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.